MEI Pharma's total assets for Q2 2025 were $24.39M, a decrease of -12.13% from the previous quarter. MEIP total liabilities were $2.29M for the fiscal quarter, a -20.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.